Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial
In brief
People with mild to moderate carpal tunnel syndrome were randomised to a single ultrasound-guided platelet-rich plasma (PRP) injection or to wearing a night splint. At six months, the authors report less pain, better symptom and function scores and reduced nerve swelling in the PRP group, and describe PRP as safe in this setting.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial Authors: Yung-Tsan Wu, Tsung-Yen Ho, Yu-Ching Chou, Ming-Jen Ke, Tsung-Ying Li, Guo-Shu Huang, Liang-Cheng Che Link: https://pubmed.ncbi.nlm.nih.gov/28273894/ Year of Publication: 2017
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

